Measles in France: Surveillance Data as of September 19, 2018

Measles is currently affecting several regions in France, and the rapid increase in the number of cases since the beginning of the year raises concerns about a new major outbreak across the country. In light of this, Santé publique France has issued an update and reminds the public that vaccination is the only way to protect against measles.

After declining between 2012 and 2016, the number of measles cases has been rising sharply since November 2017. This situation is the result of insufficient vaccination coverage among infants (79% with two doses of the vaccine instead of the required 95%), children, and young adults. The sharp increase in the number of cases since November 2017 in Nouvelle-Aquitaine has continued into 2018, with several outbreaks occurring in this region as well as in other French regions.

Epidemiological situation in France as of September 19, 2018

  • Trend in the weekly incidence of reported cases: rapid decline since the epidemic peak (Week 13), followed by stabilization around 40 weekly cases (Weeks 21 to 26); then an average of 17 cases between Weeks 27 and 31, and fewer than 10 cases over the past 6 weeks

  • As of September 16, 2018, 2,779 cases reported since November 6, 2017, including 2,702 in 2018

  • 86 departments reported at least 1 case during the period, but currently no region is reporting an active outbreak

  • Highest incidence among children under 1 year of age: 30.2 cases per 100,000 inhabitants

  • 23% of reported cases were hospitalized

  • 89% of measles cases occurred in unvaccinated or incompletely vaccinated individuals

  • 3 deaths since the beginning of 2018

Cumulative incidence and number of reported measles cases, by department, from November 6, 2017, to September 16, 2018 (provisional data, n=2,779)

alternative text

Learn more: Measles Epidemiological Bulletin. Surveillance data as of September 19, 2018.

A person with measles can infect 15 to 20 people

Measles is a highly contagious and potentially serious viral infection for which there is no curative treatment. It is a disease that affects not only young children but also adolescents and young adults. Measles is caused by a respiratory virus that spreads through the projection of saliva or respiratory droplets, particularly when coughing or sneezing. Measles cases are contagious starting about four days before the rash appears and remain so for up to about four days after the rash begins.

Vaccination is the only way to protect against measles

Santé publique France emphasizes the need for very high vaccination coverage in the population (at least 95% with two doses of vaccine among children and young adults). Such herd immunity would help eliminate the disease and its complications, thereby also protecting the most vulnerable individuals who cannot be vaccinated themselves (infants under one year of age, pregnant women, and immunocompromised individuals). It is therefore imperative that all individuals born in or after 1980 have received two doses of the vaccine.

As of January 1, 2018, measles vaccination is mandatory for infants, who must receive one dose of the combined Measles-Mumps-Rubella (MMR) vaccine at 12 months of age and a second dose between 16 and 18 months.

The more people who are vaccinated, the lower the risk of an epidemic.

alternative text

Vaccination effectiveness for community protection

Learn more:

Vaccination-info-service (page dedicated to measles): http://www.vaccination-info-service.fr/Les-maladies-et-leurs-vaccins/Rougeole

Information tools:/10000/themes/rougeole/outils.asp

Measles: Understanding to Take Action: /10000/themes/rougeole/comprendre-agir.asp

Measles outbreak in France. Updated surveillance data/Thematic-files/Infectious-diseases/Vaccine-preventable-diseases/Measles/News-updates